Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE987B01026 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Apr 15, 16:01
1091.65 15.00 (1.39%)
Volume
AVERAGE VOLUME
5-Day
80,328
10-Day
76,293
30-Day
86,611
27,734
  • Prev. Close

    1076.65

  • Open Price

    1084.65

  • Bid Price (Qty.)

    1091.65 (1)

  • Offer Price (Qty.)

    1095.00 (30)

NSE Live

Apr 15, 15:56
1091.50 14.25 (1.32%)
Volume
AVERAGE VOLUME
5-Day
882,455
10-Day
1,115,476
30-Day
1,128,957
561,394
  • Prev. Close

    1077.25

  • Open Price

    1089.50

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    1091.50 (156)

Get full access to SWOT Analysis of stock with Moneycontrol Pro.

Strengths (13)
  • Company with high TTM EPS Growth
  • Near 52 Week High

Get full access to SWOT Analysis of stock with Moneycontrol Pro.

Weaknesses (3)
  • Promoter decreasing their shareholding
  • Decline in Net Profit (QoQ)

Get full access to SWOT Analysis of stock with Moneycontrol Pro.

Opportunities (7)
  • High ROCE, Low PE companies
  • Companies with Price to Earnings (PE) less than average 3 Year PE, 5 Year PE and 10 Year PE

Get full access to SWOT Analysis of stock with Moneycontrol Pro.

Threats (2)
  • Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
  • RSI Bearish Crossovers (Daily)

Advisory Alert:

It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347